ASA: Nearly one in five people develop dementia after stroke
Feb 08, 2024
In the first year after stroke, there is an almost threefold higher risk for dementia.
Lower Alzheimer’s risk seen with PDE5i initiation for erectile dysfunction
Feb 08, 2024
The greatest reduction in risk was seen for those receiving 21 to 50 phosphodiesterase type 5 inhibitor prescriptions.
Healthier lifestyle linked to better global cognition close to death
Feb 06, 2024
Neither the strength nor the significance of the association was changed when common dementia-related brain pathologies were included in the model.
Missed, undiagnosed cirrhosis may be risk factor for cognitive decline
Feb 02, 2024
More than 5% of veterans with dementia had a Fibrosis-4 score greater than 3.25, suggestive of cirrhosis.
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
Strategies needed to improve delivery of Alzheimer’s disease-modifying therapies
Jan 30, 2024
Models that enable primary care practitioners to diagnose disease and evaluate patients for treatment eligibility would have biggest effect on wait times, the study found.
Monoclonal antibodies provide small benefits in Alzheimer’s disease
Jan 26, 2024
Harms include increased risks for amyloid-related imaging abnormalities (ARIA)-edema, ARIA-hemorrhage and symptomatic ARIA-edema.
Adult day services with specialized care have higher proportion with dementia
Jan 25, 2024
42.2% of clients have dementia in adult day services centers providing specialized care versus 22.7% in nonspecialized centers.
Ordering palliative care consult by default increases rate of consultation
Jan 22, 2024
The findings were seen in older hospitalized patients with advanced chronic obstructive pulmonary disease, dementia or kidney failure.
Study IDs proportion of dementia cases attributable to known risk factors
Jan 19, 2024
The population-attributable fraction for nongenetic risk factors combined is similar for men and women, but it varies across racial and ethnic groups.